Sepha's Multi-bottle Leak and Seal Tester - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Sepha's Multi-bottle Leak and Seal Tester



Untitled Document

Sepha, a Belfast, Ireland based company launched BottleScan, a multibottle integrity tester for induction-sealed pharmaceutical bottles. BottleScan uses force-decay technology to detect weak seals and defects down to 15 microns. It has a toolless design and can test up to four bottles simultaneously in a cycle of approximately 60 seconds. The system produces objective, pass-or-fail results enabling good bottles to be returned to the production line. BottleScan has the ability to run in compliance with 21 CFR Part 11, offering pharmaceutical manufacturers and packagers a solution for testing the integrity of induction-sealed bottles.

Source: Sepha

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here